CVE-2022-47376: The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the inst
27
Routine
HIGH 7.3UPGRADE
CVE-2022-47376 is a high-severity flaw (CVSS 7.3) affecting alaris infusion central. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.
Downgrading can break dependent software and may reopen older bugs. Read the distro advisory first and test on a non-production host.
After downgrade
Restart the service, and keep the package held until a fixed release ships.
Verify at the official sourceNVD · CVE Program · Report a problem with this page Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2022-47376?
alaris infusion central: upgrade to newer than 1.3.2. Exact commands for each OS are on this page.
Is CVE-2022-47376 being exploited?
CVE-2022-47376 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2022-47376 affect?
CVE-2022-47376 affects alaris infusion central. Severity is high (CVSS 7.3). The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.